ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Sevilla, AN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Lung Diseases
Rhinitis
Chronic Obstructive Pulmonary Disease
Disease
Dust Mite Allergy

Asthma trials near Sevilla, AN, ESP:

Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma (Polaris)

dose-range finding study in adults with moderate to severe asthma to confirm the dosing regimen of WIN378 that can be tested in future pivot...

Enrolling
Asthma
Drug: Placebo
Drug: WIN378

Phase 2

Windward Bio

Seville, Sevilla, Spain and 72 other locations

Locations recently updated

The objective of this study is to assess the potential for GB-0895 to improve the health of adolescents and adults with severe asthma that i...

Enrolling
Severe Asthma
Drug: GB-0895
Drug: Placebo

Phase 3

Generate Biomedicines

Seville, Sevilla, Spain and 156 other locations

This study is trying to find the right dose of a long-lasting medicine called GSK5784283 for people with asthma that remains uncontrolled ev...

Active, not recruiting
Asthma
Drug: GSK5784283
Drug: Placebo

Phase 2

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Seville, Spain and 137 other locations

propionate in children from 12 to less than 18 years of age with asthma with pre-bronchodilator FEV1 ≥ 50 % of the predicted normal value fo...

Enrolling
Asthma
Drug: Salmeterol Xinafoate / Fluticasone Propionate
Drug: Placebo to QVM149

Phase 3

Novartis
Novartis

Seville, Spain and 21 other locations

treatment in children 2 to \<6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze. The study will be conducted i...

Invitation-only
Asthma
Wheezing
Drug: Placebo
Drug: Dupilumab

Phase 3

Sanofi
Sanofi

Jerez de la Frontera, Cádiz, Spain and 74 other locations

and safety with subcutaneous immunotherapy in patients with mild to moderate rhinitis / rhinoconjunctivitis with or without mild to moderate asthma...

Enrolling
Asthma, Allergic
Rhinoconjunctivitis
Other: Placebo
Biological: 30,000 MG01 + 10,000 T517

Phase 3

Inmunotek

Sevilla, Spain and 31 other locations

experimental drug called CHF5993 pMDI compared to the currently approved Seretide 125 Evohaler pMDI in adolescent patients with uncontrolled asthma...

Begins enrollment this month
Asthma
Drug: Seretide Evohaler
Drug: CHF5993 100/6/12.5 μg pMDI HFA-152a

Phase 3

Chiesi
Chiesi

Jerez de la Frontera, Spain and 24 other locations

This Phase 2b study is designed to evaluate the safety and efficacy of KT-621 in participants with uncontrolled moderate to severe eosinophilic asthma...

Enrolling
Eosinophilic Asthma
Drug: KT-621
Other: Placebo

Phase 2

Kymera Therapeutics

Jerez de la Frontera, Spain and 80 other locations

in patients with rhinitis/rhinoconjunctivitis with or without asthma, sensitised to Dermatophagoides pteronyssinus and /or Dermatophagoides ...

Enrolling
Asthma, Allergic
Rhinoconjunctivitis
Biological: 10,000 MM09
Biological: 30,000 MM09

Phase 3

Inmunotek

Sevilla, Spain and 31 other locations

This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma.The purpose of this...

Active, not recruiting
Asthma
Drug: Budesonide/Albuterol
Drug: Lunsekimig

Phase 2

Sanofi
Sanofi

Seville, Spain and 230 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems